Regulon

Regulon: R-473

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
21-0.89566710Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5725 ENSG00000011304 PTBP1 A6NLN1
54455 ENSG00000037637 FBXO42 X6RKU3
9733 ENSG00000075856 SART3 Q15020
79728 ENSG00000083093 PALB2 Q86YC2
10523 ENSG00000085872 CHERP Q8IWX8
22938 ENSG00000100603 SNW1 Q13573
79882 ENSG00000100722 ZC3H14 G3V411
6421 ENSG00000116560 SFPQ P23246
10274 ENSG00000118007 STAG1 Q8WVM7
10657 ENSG00000121774 KHDRBS1 Q07666
10155 ENSG00000130726 TRIM28 Q13263
10250 ENSG00000133226 SRRM1 Q8IYB3
3178 ENSG00000135486 HNRNPA1 P09651
25800 ENSG00000141424 SLC39A6 Q13433
4841 ENSG00000147140 NONO Q15233
9919 ENSG00000148396 SEC16A O15027
1105 ENSG00000153922 CHD1 O14646
22976 ENSG00000157212 PAXIP1 Q6ZW49
26130 ENSG00000165219 GAPVD1 Q14C86
5747 ENSG00000169398 PTK2 E5RH01
5394 ENSG00000171824 EXOSC10 Q01780

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
LADIRATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor20
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-473

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs